Sarepta Therapeutics (SRPT) Profit After Tax Growth (5y) (2015 - 2026)
Sarepta Therapeutics (SRPT) Profit After Tax Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Sarepta Therapeutics |
1.61 Bn |
923.39 Mn |
291.52 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
31.81% |
| Dec 31, 2025 |
-16.84% |
| Sep 30, 2025 |
23.77% |
| Jun 30, 2025 |
27.01% |
| Mar 31, 2025 |
-91.25% |
| Dec 31, 2024 |
21.75% |
| Sep 30, 2024 |
17.78% |
| Jun 30, 2024 |
15.14% |
| Mar 31, 2024 |
19.84% |
| Dec 31, 2023 |
18.37% |
| Sep 30, 2023 |
11.73% |
| Jun 30, 2023 |
26.19% |
| Mar 31, 2023 |
-70.98% |
| Dec 31, 2022 |
-35.41% |
| Sep 30, 2022 |
-40.11% |
| Jun 30, 2022 |
-29.71% |
| Mar 31, 2022 |
-26.58% |
| Dec 31, 2021 |
-6.64% |
| Sep 30, 2021 |
3.23% |
| Jun 30, 2021 |
-5.49% |
